Lyndra Therapeutics’ $55 Million Series B Financing


Sidley represented HOPU Investments in a $55 million Series B preferred stock financing by Lyndra Therapeutics, a developer of an orally administered steady-state release pill.

Hopu Investment Management Co Ltd operates as a private equity firm. The Company serves customers in China.

Other investors include Polaris Partners, an existing investor of Lyndra Therapeutics that led this round, Gilead Sciences, Invus, the Bill & Melinda Gates Foundation and Orient Life.

The Sidley team was led by partner Ruchun Ji (Picture) with assistance from partner Tom Duley (San Francisco) and associate Ian Day (Los Angeles).

Involved fees earner: Ian Day – Sidley Austin LLP; Thomas Duley – Sidley Austin LLP; Ruchun Ji – Sidley Austin LLP;

Law Firms: Sidley Austin LLP;

Clients: Hopu Investment Management;